Eagle Pharmaceuticals, Inc. (EGRX) Social Stream
EAGLE PHARMACEUTICALS INC (EGRX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering EAGLE PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 4 | $52 | $46 | $49.666 | $5.13 | 868.15% |
| 2022-02-09 | 4 | $52 | $50 | $51 | $5.13 | 894.15% |
| 2022-03-31 | 4 | $52 | $49 | $50.333 | $5.13 | 881.15% |
| 2022-04-28 | 3 | $50 | $49 | $49.5 | $5.13 | 864.91% |
| 2022-06-06 | 3 | $50 | $47 | $48.5 | $5.13 | 845.42% |
| 2022-11-07 | 3 | $45 | $41 | $43 | $5.13 | 738.21% |
| 2022-11-08 | 3 | $41 | $37 | $39 | $5.13 | 660.23% |
| 2023-03-13 | 3 | $37 | $31 | $34 | $5.13 | 562.77% |
| 2023-03-14 | 3 | $33 | $31 | $32 | $5.13 | 523.78% |
| 2023-05-10 | 3 | $33 | $26 | $29.5 | $5.13 | 475.05% |
| 2023-07-25 | 2 | $26 | $26 | $26 | $5.13 | 406.82% |
| 2023-08-09 | 2 | $17 | $17 | $17 | $5.13 | 231.38% |
| NA | 1 | $NA | $NA | $NA | $5.13 | NA% |
The Trend in the Analyst Price Target
EGRX's average price target has moved down $34.67 over the prior 39 months.
Over the past 149 days, EGRX's average upside potential has been 26.75%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-14 | 3 | 33 | 31 | 32.0 | 25.62 | 24.9% |
| 2023-05-10 | 3 | 33 | 26 | 29.5 | 21.11 | 39.74% |
| 2023-05-10 | 2 | 33 | 26 | 29.5 | 21.11 | 39.74% |
| 2023-07-25 | 2 | 26 | 26 | 26.0 | 18.36 | 41.61% |
| 2023-08-09 | 2 | 17 | 17 | 17.0 | 19.23 | -11.6% |
EGRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 1 | 0 | 0 | 1 | 1 | 2 |
The Trend in the Broker Recommendations
Over the past 153 days, EGRX's average broker recommendation rating worsened by 0.67.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- EGRX has a greater number of analysts covering the stock than 113.59% of all US stocks.
- EGRX has a higher upside potential (average analyst target price relative to current price) than 1331.9% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, EAGLE PHARMACEUTICALS INC's variance in analysts' estimates is lower than 32.6% of them.
- In the context of stocks in the small market cap category, EAGLE PHARMACEUTICALS INC's average analyst price target is greater than 1138.59% of them.
In the Pharmaceutical Products industry, CPRX, LXRX, and ANIP are the three stocks most similar to EAGLE PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is EGRX a Buy, Hold or Sell? See the POWR Ratings now!